RecruitingPhase 4NCT06582680

Aging, Beta Blockers, and Thermoregulatory Responses


Sponsor

University of Texas Southwestern Medical Center

Enrollment

22 participants

Start Date

Oct 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will test the hypothesis that the drugs propranolol and metoprolol will result in greater increases in core body temperature during 3 hours of extreme heat exposure in older adults.


Eligibility

Min Age: 65 Years

Inclusion Criteria5

  • Healthy and free of any significant medical problems
  • Normal resting electrocardiogram
  • + years of age
  • Controlled cholesterol of less than 200 mg/dl
  • Controlled blood pressure of less than 140/90 mmHg

Exclusion Criteria5

  • Known diseases or other chronic conditions requiring regular medical therapy including cancer, diabetes, neurological diseases, uncontrolled hypertension, and uncontrolled hypercholesterolemia
  • Serious abnormalities detected on routine screening
  • Taking prescribed medications or over-the-counter medications that have known influences on either cardiac function or sweating
  • Current smokers, as well as individuals who regularly smoked within the past 3 years
  • body mass index ≥31 kg/m2

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAmbient Heat

Subjects will spend 3-hours in a heat chamber at 41°C and 40% humidity.


Locations(1)

IEEM Texas Health Presbyterian Hospital Dallas

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06582680


Related Trials